Review of antimicrobials for acute rhinosinusitis

Acute bacterial rhinosinusitis in adults is a common malady, with between 30 to 35 million cases a year.

These patients are seen by a range of practitioners, from primary care physicians to otolaryngologists.

Findings from a meta-analysis that examined the use of antibiotics for treatment of these patients are presented at the 2007 AAO-HNSF Annual Meeting & OTO EXPO. Researchers noted several interesting points revealed in their research, including that the natural course of acute rhinosinusitis in adults is more prolonged than traditionally thought. Only a small minority of patients are cured or report improvement after 3 to 5 days, even when treated with an antibiotic. A second finding showed that antibiotics do provide a benefit in regard to the number of patients improved or cured, but only 7 to 12 days after initiation of treatment with antibiotics. Before 7 days, antibiotics do not provide a significant advantage, compared to treating simply with a placebo. An additional finding is the significant frequency at which negative side effects, such as gastrointestinal upset and diarrhea, occur with antibiotic treatment.

Findings from the study may help to determine a natural history of acute rhinosinusitis in adults, and what to expect when antimicrobial therapy is administered.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
HNL Dimer as a promising biomarker for monitoring antibiotic treatment in sepsis